Clinical Trials Browser

Completed × Maraviroc × Clear all

NCT04721301 2023-10-17

Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial

Phase 1 Completed

Gastrointestinal

Colorectal Cancer Metastatic

NCT03274804 2022-06-07

PICCASSO

Phase 1 Completed

20 enrolled 12 charts

Gastrointestinal

Colorectal Neoplasms

NCT01276236 2021-03-05

Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)

Phase 2 Completed

13 enrolled 16 charts

Sarcoma, Kaposi

NCT01785810 2021-01-11

Phase II Maraviroc for GVHD Prevention

Phase 2 Completed

37 enrolled 17 charts

Other hematologic neoplasm

Hematologic Neoplasms

NCT02208037 2019-01-23

Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

Phase 2 Completed

279 enrolled 28 charts

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01736813 2017-03-22

MARACON

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT01329783 2011-05-16

EuroSIDA As An External Comparator To MOTIVATE Trials

Acquired Immunodeficiency Syndrome